Navigation Links
Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin(R) (MP-376) Treatment in Cystic Fibrosis Patients
Date:9/10/2009

SAN DIEGO, Sept. 10 /PRNewswire/ -- Mpex Pharmaceuticals, Inc. today announced positive data from its Phase 2b clinical trial with Aeroquin((R)) (a novel aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF). Trial results showed that nebulized Aeroquin met the primary endpoint of reducing bacterial counts of Pseudomonas aeruginosa (P. aeruginosa) in sputum after 28 days of dosing versus placebo. Clinically and statistically significant improvements versus placebo were also seen in a number of important clinical endpoints, including FEV1, percent predicted FEV1, FEF25-75 (all measures of respiratory function) and time to need for anti-pseudomonal antibiotics (a measure of exacerbations). Both once and twice-daily dosing of Aeroquin showed activity in this trial, with higher doses showing improved responses. Aeroquin was well tolerated and no significant change in antibiotic resistance was observed in this study. Detailed results will be presented at a major respiratory meeting in the near future

The Phase 2b, multi-center randomized, double-blind, placebo-controlled trial (Mpex 204) studied 151 CF patients to evaluate the safety, tolerability and efficacy of inhaled Aeroquin administered for 28 days using an Investigational eFlow Nebulizer System (PARI Pharma GmbH). Patients were then followed for an additional 28 days after completion of dosing. The trial was conducted in the U.S., Germany and the Netherlands.

To ensure that results from this trial were as predictive as possible for a future Phase 3 program, Mpex 204 enrolled patients that have recently received multiple courses of inhaled antibiotics and in most cases were already receiving other medication shown to improve lung function and reduce exacerbations. To be eligible for the trial, CF patients had to have received at least three 28 day cycles of other inhaled antibiotic therapy over the previous 12 m
'/>"/>

SOURCE Mpex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer
2. Rib-X Pharmaceuticals to Present at the 49th ICAAC
3. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009
4. Dont Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains
5. EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer
6. Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog
7. Wilmington Pharmaceuticals Receives FDA Approval for Orally Disintegrating Metoclopramide Tablet
8. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
9. Alexza Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. Trubion Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
11. Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Boston, MA (PRWEB) May 19, 2013 ... providing social media training online, has proudly announced that ... for small business has surpassed 175,000 views on YouTube. ... free social media and SEO tips and training for ... see my students find the YouTube tips helpful for ...
(Date:5/17/2013)... May 17, 2013 Topricin Pain ... Inc., has been listed among nationally recommended over-the-counter ... initiative conducted by "U.S. News" Health in collaboration ... the “No. 1 Pharmacists Recommended designation” in ... national OTC brands, and is the only homeopathic ...
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine and Professor ... Einstein College of Medicine and Associate Chairman of the ... He is also Associate Director for Clinical Research at ... Cancer Working Group, a multidisciplinary group of physicians and ... serves as Vice Chair of the National Cancer Institute ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Oven Industries ... capabilities. The 5R6-900 temperature controller has many user-friendly benefits. ... plugged into the wall as a self-contained temperature ... This distinctive detail makes the device unique, as well ... controller can also be used universally, which allows the ...
Breaking Biology Technology:YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3New Temperature Control Products Announced by Oven Industries Inc. 2
... , June 25 Ruedi Waeger , Ph.D., former president ... of Directors, was honored with the Robert W. Reilly Leadership award June ... , , , ... Plasma Protein Therapeutics Association (PPTA) and recognizes individuals who exemplify the leadership qualities ...
... Beardsworth Consulting Group, Inc. announces the appointments of ... Robert W. Malone , M.D. as the company,s Medical Director, Vaccines. ... Dr. Alison Martin ... of clinical research experience.  She joins Beardsworth from the National Cancer Institute ...
... HOPKINTON, Mass. , June 25 Caliper Life ... and services for drug discovery and life sciences research, hosted its ... 9 and 10. This thought-leadership conference is focused on sharing ... process, leading to the next generation of breakthrough diagnostics and therapies. ...
Cached Biology Technology:Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award from Plasma Protein Therapeutics Association 2Alison Martin, MD and Robert W. Malone, MD Join Beardsworth 2Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life 2Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life 3
(Date:5/18/2013)... Research Foundation is honored to announce the first AGA-Caroline ... which will support Andrew D. Rhim, MD, from the ... Philadelphia, as he furthers his research on the role ... , "The AGA Research Foundation is humbled to issue ... AGA Legacy Society members," said Nicholas F. LaRusso, MD, ...
(Date:5/18/2013)... presented today at Digestive Disease Week (DDW) explores new ... impact of coffee on autoimmune disease and palliative care ... has been associated with reduced risk of fibrosis, a ... of java each month also correlate with lower risk ... Mayo Clinic, Rochester, MN, linked coffee consumption with reduced ...
(Date:5/18/2013)... (May 18, 2013) Research presented at Digestive ... digestive health through diet and lifestyle. , ... by reduced muscle strength, fatigue and poor quality ... patients are in remission. A randomized, double blind, ... vitamin D supplementation corresponded to significant relief of ...
Breaking Biology News(10 mins):AGA Research Foundation grant furthers digestive cancer research 2Coffee consumption associated with reduced risk of autoimmune liver disease 2Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3
... the world today agreed at a meeting in Canada to ... in leadership related to global water issues. Saying ... say the panel will work to elevate the issue,s political ... The 20 members of the InterAction Council attending this ...
... structures on the smallest possible scales using molecules ... physically and conceptually challenging. An interdisciplinary team of researchers ... method of computationally selecting the best of these blocks, ... making biological structures. The team was led by ...
... University shows that so-called biodegradable products are likely doing ... releasing a powerful greenhouse gas as they break down. ... are broken down in landfills by microorganisms that then ... paper describing the research and professor and head of ...
Cached Biology News:Void in leadership on world water crisis cited by 20 former heads of government 2Penn researchers help nanoscale engineers choose self-assembling proteins 2Penn researchers help nanoscale engineers choose self-assembling proteins 3Study: Biodegradable products may be bad for the environment 2
... For microsatellite research, the 4300 System features ... automation software available. SagaGT automates electrophoresis, lane ... sizes, and allele scoring. ,Saga GT ... Saga 1.0 (Unix) was initially developed at ...
... BioPrime Plus Array CGH Genomic Labeling Systems ... reproducible labeling of genomic DNA samples for ... both indirect and direct labeling formats, the ... provide a flexible solution to your genomic ...
Request Info...
... E. coli containing a clone of the human ... Topoisomerase II alters the topological state of nucleic ... a transient break which generates a separate DNA ... double-stranded DNA passage mechanism, the enzyme can relax ...
Biology Products: